IBL/Inselzell Ak ELISA/NM59081/
市场价:
¥0.00
美元价:
0.00
产品分类:
夹心法ELISA
公司分类:
Sandwich_method_ELISA
联系Q Q:
3392242852
电话号码:
4000-520-616
电子邮箱:
info@ebiomall.com
商品介绍
Kitsize | 12x8 |
Method | ELISA |
Incubationtime | 2x1h,1x30min |
Standardrange | negativeandpositivecontrol |
Specimen/Volumes | 25µLserum |
Substrate/isotope | PNPP405nm |
RegulatoryStatus: | EU:CE |
Detailsfor: Inselzell-AkELISA
Insulin-dependentdiabetesmellitus(IDDM)orTypeIDiabetesisadebilitatingchronicdiseasethatimpairsproductionandsecretionofthekeyhormoneinsulinandaltersbloodsugarmetabolism.InsulinissynthesisedandsecretedbypancreaticisletcellsorisletsofLangarhans.ThedisruptionofinsulinsynthesisiscausedbyimmunologicaldestructionoftheisletcellsbyautoantibodiesinIDDMpatients.Suchabnormalities(autoimmunity)maybegeneticallyinheritedand/ortriggeredbyexposuretotoxicchemicals,viralinfectionsandvariousformsofstress.IDDMhasacharacteristicasymptomaticprediabeticphasethatmaylastuptoseveralyears.Duringthisperiod,theaffectedindividualsexhibitthediminishingearly-phasereleaseofinsulininresponsetoanintravenous/oralglucosechallenge.Inthemajorityofcases,theseindividualscarrycirculatingisletcellautoantibodies(ICA)and/orinsulinautoantibodies(IAA).ICAcanbedetectedasearlyaseightyearspriortotheclinicalonsetofIDDMandthusmayserveasanearlyindicatorofthediseaseorofpredispositiontoit.IndividualswhoareICA-positivemayshowaprogressivelossoftheisletcellfunctionasindicatedbydisruptionoftheearly-phaseinsulinrelease.Whenthisearlyphaseinsulinreleasecompletelystops,clinicallyovertIDDMdevelops.ICAarepresentin70%ofpatientswithrecentonsetofIDDMcomparedwith0.1-0.5%ofthecontrolnon-diabeticpopulation.ICAarealsodetectedinfirstdegreerelativesofIDDMpatients.TheseindividualscomprisethesegmentofhumanpopulationwhoareatahighriskofdevelopingIDDM.SeveralstudiesreportedthattheICA-positivefirstdegreerelativesofIDDMpatientssubsequentlydevelopeddiabetes.OtherstudiesalsosuggestedthatthepresenceofserumICAandIAAisanindicatorortheenhancedlikelihoodtodevelopIDDM.Therefore,SEROlogicaldetectionofICAmaybeapowerfultoolforearlydiagnosisofIDDM.ThesignificanceoftheseautoantibodiesasMarkersofIDDMisalsoillustratedbytheirpresenceinnondiabeticindividualswhoultimatelydevelopIDDM.Riley,et.al.recentlyreportedthatdeterminationofICAinType2DiabetespatientscouldidentifyIDDMpriortotheonsetofclinicalsymptomsandpredicttheneedforinsulintherapy.Thus,thosepatientswhoareinitiallydiagnosedwithType2DiabetesandcarryserumICAmaydeterioratetoinsulindependence.EarlydetectionofcirculatingICAisimportanttoidentifytheindividualsinthegeneralpopulation,thesIBLingsandfamiliesofIDDMpatientswhoareatahigherriskofdevelopingthisdiseasebecauseoftheirgeneticpredispositiontodiabetes.AtarecentinternationalworkshoponICA,theimminentneedforanELISAtestforthedeterminationofisletcellautoimmunitywasemphasized.Currently,serumICAaredeterminedbyindirectimmunofluorescenceandhistochemicalmethodsemployingfrozenunfixedhuman/primateorratpancreaticsectionsassubstrates.Despitevariousattemptstoimproveandmodifythisproceduresinceitsoriginaldescriptionin1974,theindirectimmunoflourescence/histochemicaltechniquesuffersfrominherentmethodologicalproblems.Standardisationofthetechniquehasproventobeverydifficult.ThereliABIlityofthis"frozen-section"techniqueislimitedbyfactorssuchasthevariationfromonepancreastoanother,theinevitableneedforunfixedpancreatictissueandinfrequentavailabilityofthesuitabletissue.ThisICAtestisaqualitativeELISAtestforinvitrodetectionofcirculatingIgGantibodiesagainstpancreaticisletcellantigens.
ForconcretedatapleaseconsulttheInstructionforUseinthedownloadboxontherightside.品牌介绍
IBL我们的愿景是通过Tecan技术,产品和支持,为世界各地的每个实验室提供支持。我们旨在通过无与伦比的专业知识,产品和客户支持来塑造生命科学和临床诊断自动化工作流程的未来。